The Syringe Market is estimated to be valued at US$ 14,839.3 Mn in 2021 and is expected to exhibit a CAGR of 8.0% over the forecast period (2022-2028), as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The syringe market is driven by the increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases, which require frequent medication and injections. Additionally, the growing adoption of self-administration devices for home healthcare settings has further contributed to the market growth. Syringes are widely used in healthcare settings for various purposes, including medication administration, vaccination, and blood collection. The market offers a wide range of syringes, including safety syringes, insulin syringes, prefilled syringes, and disposable syringes, among others, catering to the diverse needs of healthcare professionals and patients.
Market Dynamics:
The two key drivers of the syringe market are the rising prevalence of chronic diseases and the increasing adoption of self-administration devices. The increasing burden of chronic diseases worldwide has led to a surge in the demand for medications and injections, driving the demand for syringes. Furthermore, the growing trend of self-medication and home healthcare has resulted in the increased use of self-administration devices such as prefilled syringes and insulin pens. These devices offer convenience and ease of use, providing patients with better control over their treatment. Overall, the syringe market is expected to witness significant growth in the forecast period, driven by these drivers.
SWOT Analysis:
Strengths: The syringe market has a strong global demand due to its essential role in healthcare settings for administering medications and collecting blood samples. The market is driven by the increasing prevalence of chronic diseases and the growing geriatric population. Additionally, advancements in syringe technologies, such as safety features and auto-injectors, are further boosting market growth.
Weaknesses: One weakness of the syringe market is the risk of needlestick injuries, which can lead to the transmission of infectious diseases. Another weakness is the lack of standardization in syringe sizes and types, which can cause confusion and errors in medical procedures.
Opportunities: The syringe market presents opportunities for innovation and product development. There is a growing demand for prefilled syringes, which offer convenience and reduce medication errors. Moreover, increasing investments in healthcare infrastructure, especially in developing economies, provide opportunities for market expansion.
Threats: The syringe market faces the threat of counterfeit and low-quality products, which can compromise patient safety. Additionally, stringent regulatory requirements and the high cost of syringe manufacturing are potential threats to market growth.
Key Takeaways:
The global syringe market Share is expected to witness high growth, exhibiting a CAGR of 8.0% over the forecast period of 2022-2028. This growth is driven by the increasing prevalence of chronic diseases and the growing geriatric population worldwide. Among regions, Asia Pacific is the fastest-growing and dominating region in the syringe market, attributed to the rising healthcare expenditure and expanding healthcare infrastructure in countries like China and India. Key players operating in the syringe market include Catalent Inc., Smiths Medical Inc., Cardinal Health, Schott, Nipro Corporation, Terumo Corporation, Gerresheimer AG, B. Braun Melsungen AG, Becton, Dickinson and Company, Codan Medizinische Geräte GmbH & Co. KG, and Hindustan Syringes & Medical Devices Limited, among others. These companies are actively involved in product development, partnerships, and mergers to strengthen their market position.
Read More,
https://www.trendingwebwire.com/future-prospects-and-market-trends-size-and-share-analysis-2/